https://mml.aeb.mwp.accessdomain.com/about-rothwellfigg/about-bg/ 2016-05-14T14:37:44+00:00 https://mml.aeb.mwp.accessdomain.com/home/biosimilars-header-aboutrfem/ 2017-01-20T00:04:28+00:00 https://mml.aeb.mwp.accessdomain.com/2017/01/15/nonproprietary-naming-biological-products/nonproprietary-naming-of-biological-products/ 2017-02-16T20:31:53+00:00 https://mml.aeb.mwp.accessdomain.com/2017/01/20/fda-issues-draft-guidance-demonstrating-interchangeability/considerations-in-demonstrating-interchangeability-with-a-reference-product/ 2017-02-24T21:03:40+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00822-patent-no-9085619/ 2017-02-27T14:59:11+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00822-patent-no-90875619-petition-filed/ 2017-02-27T14:59:30+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00823-patent-no-9085619/ 2017-02-27T15:00:53+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00823-patent-no-9085619-petition-filed/ 2017-02-27T15:01:09+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00826-patent-no-9085619/ 2017-02-27T15:02:43+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00826-patent-no-9085619-petition-filed/ 2017-02-27T15:03:32+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00827-patent-no-9085619/ 2017-02-27T15:04:56+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00827-patent-no-9085619-petition-filed/ 2017-02-27T15:08:10+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00408-patent-no-8889135/ 2017-02-27T15:11:15+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00408-patent-no-8889135-trial-instituted/ 2017-02-27T15:11:27+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00409-patent-no-8889135/ 2017-02-27T15:15:34+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00409-patent-no-8889135-2/ 2017-02-27T15:16:09+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00409-patent-no-8889135-trial-instituted/ 2017-02-27T15:16:21+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00172-patent-no-8889135/ 2017-02-27T15:18:06+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00172-patent-no-8889135-trial-instituted/ 2017-02-27T15:19:10+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00188-patent-no-9017680/ 2017-02-27T15:21:39+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00188-patent-no-9017680-trial-instituted/ 2017-02-27T16:49:08+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00189-patent-no-9073987/ 2017-02-27T16:50:34+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00189-patent-no-9073987-2/ 2017-02-27T16:50:54+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00189-patent-no-9073987-trial-instituted/ 2017-02-27T16:51:15+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-01018-patent-no-9114166/ 2017-02-27T16:52:42+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-01018-patent-no-9114166-terminated-institution-denied/ 2017-02-27T16:53:00+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01514-patent-no-8916157/ 2017-02-27T16:54:11+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01514-patent-no-8916157-terminated-institution-denied/ 2017-02-27T16:54:30+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01517-patent-no-8916158/ 2017-02-27T16:55:34+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01517-patent-no-8916158-terminated-institution-denied/ 2017-02-27T16:55:56+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01517-patent-no-8916158-terminated-institution-denied-2/ 2017-02-27T16:56:11+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00959-patent-no-8591897/ 2017-02-27T16:57:50+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00959-patent-no-8591897-petition-filed/ 2017-02-27T16:58:10+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00804-patent-no-6627196/ 2017-02-27T16:59:20+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00804-patent-no-6627196-petition-filed/ 2017-02-27T16:59:41+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00805-patent-no-7371379/ 2017-02-27T17:00:41+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00805-patent-no-7371379-petition-filed/ 2017-02-27T17:01:03+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00731-patent-no-7846441/ 2017-02-27T17:02:10+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00731-patent-no-7846441-petition-filed/ 2017-02-27T17:02:31+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00737-patent-no-7892549/ 2017-02-27T17:04:00+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00737-patent-no-7892549-petition-filed/ 2017-02-27T17:04:19+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00739-patent-no-7892549/ 2017-02-27T17:05:31+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2017-00739-patent-no-7892549-petition-filed/ 2017-02-27T17:05:58+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-01837-patent-no-7807799/ 2017-02-27T18:23:39+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-01837-patent-no-7807799-petition-filed/ 2017-02-27T18:23:59+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-1693-patent-no-6407213/ 2017-02-27T18:25:52+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-1693-patent-no-6407213-petition-filed/ 2017-02-27T18:26:09+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-1694-patent-no-6407213/ 2017-02-27T18:27:31+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-1694-patent-no-6407213-petition-filed/ 2017-02-27T18:27:51+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-01771-patent-no-7622115/ 2017-02-27T18:29:08+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-01771-patent-no-7622115-petition-filed/ 2017-02-27T18:29:52+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-1667-patent-no-7976838/ 2017-02-27T18:31:46+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-1667-patent-no-7976838-petition-filed/ 2017-02-27T18:32:12+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-1614-patent-no-7820161/ 2017-02-27T19:04:51+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-1733-patent-no-7976838/ 2017-02-27T19:07:30+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-1744-patent-no-7820161/ 2017-02-27T19:11:12+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-00415-patent-no-7820161/ 2017-02-27T19:13:26+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-00415-patent-no-7820161-terminated/ 2017-02-27T19:13:48+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-00417-patent-no-7976838/ 2017-02-27T19:15:02+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-00417-patent-no-7976838-terminated/ 2017-02-27T19:17:21+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-00418-patent-no-8329172-terminated/ 2017-02-27T19:21:09+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-00418-patent-no-8329172/ 2017-02-27T19:21:15+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-01542-patent-no-8952138-trial-instituted/ 2017-02-27T19:22:47+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-01542-patent-no-8952138/ 2017-02-27T19:22:52+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00912-patent-no-8815236-terminated/ 2017-02-27T19:24:13+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00912-patent-no-8815236/ 2017-02-27T19:24:17+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00915-patent-no-8348321-terminated/ 2017-02-27T19:25:47+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00915-patent-no-8348321/ 2017-02-27T19:25:50+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00915-patent-no-8900577-terminated/ 2017-02-27T19:27:40+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00915-patent-no-8900577/ 2017-02-27T19:27:44+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-00915-patent-no-8900577-terminated-2/ 2017-02-27T19:27:57+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01792-patent-no-8163522-terminated/ 2017-02-27T19:29:33+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01537-patent-no-8476239/ 2017-02-27T19:31:01+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01537-patent-no-8476239-final-written-decision/ 2017-02-27T19:31:26+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-01537-patent-no-8476239-2/ 2017-02-27T19:31:33+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2016-1614-patent-no-7820161-trial-instituted/ 2017-03-02T16:46:21+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-1733-patent-no-7976838-terminated-dismissed-without-prejudice/ 2017-03-02T16:48:41+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/01/rfems-biosimilar-inter-partes-review-ipr-dashboard/ipr-2015-1744-patent-no-7820161-terminated-dismissed-without-prejudice/ 2017-03-02T16:50:35+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/02/complaint-genentech-v-amgen-dismissed-without-prejudice/us-supreme-court/ 2017-03-06T03:55:24+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/02/complaint-genentech-v-amgen-dismissed-without-prejudice/laboratory-research/ 2017-03-06T03:55:29+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/02/complaint-genentech-v-amgen-dismissed-without-prejudice/glass-vials-for-liquid-samples/ 2017-03-06T03:55:34+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/02/complaint-genentech-v-amgen-dismissed-without-prejudice/abstract-network-connection-background/ 2017-03-06T03:55:39+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/02/complaint-genentech-v-amgen-dismissed-without-prejudice/legal-law-concept-image/ 2017-03-06T03:55:44+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/02/complaint-genentech-v-amgen-dismissed-without-prejudice/futuristic-earth-map-technology-abstract-background/ 2017-03-06T03:55:49+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/02/complaint-genentech-v-amgen-dismissed-without-prejudice/us-supreme-court-2/ 2017-03-06T03:56:05+00:00 https://mml.aeb.mwp.accessdomain.com/2017/02/16/fda-accepts-bla-mylan-biocon-pegfilgrastim-biosimilar/patent/ 2017-03-06T04:48:15+00:00 https://mml.aeb.mwp.accessdomain.com/2017/02/16/fda-accepts-bla-mylan-biocon-pegfilgrastim-biosimilar/the-great-seal-of-the-us-gold/ 2017-03-06T04:48:19+00:00 https://mml.aeb.mwp.accessdomain.com/2017/01/15/nonproprietary-naming-biological-products/pharmacy-and-rx-symbol/ 2017-03-06T05:10:02+00:00 https://mml.aeb.mwp.accessdomain.com/2017/02/28/ptab-institutes-ipr-filed-celltrion-rituximab-patent/wooden-brown-judges-gavel-isolated-on-black/ 2017-03-06T20:44:28+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/22/sanofi-regeneron-seek-declaratory-judgment-dupixent-dupilumab-not-infringe-amgens-patent/sanofi-v-amgen-complaint/ 2017-03-22T21:05:36+00:00 https://mml.aeb.mwp.accessdomain.com/2017/03/22/sanofi-regeneron-seek-declaratory-judgment-dupixent-dupilumab-not-infringe-amgens-patent/u-s-patent-no-8679487/ 2017-03-22T21:06:40+00:00 https://mml.aeb.mwp.accessdomain.com/2017/04/12/immunex-files-patent-infringement-suit-dupixent-dupilumab-seeks-dismiss-transfer-sanofi-regenerons-prior-dj-complaint/immunex-v-sanofi-et-al-complaint/ 2017-04-12T19:56:22+00:00 https://mml.aeb.mwp.accessdomain.com/2017/04/19/litigation-spotlight-infliximab-remicade-litigation/rf_rot_172628414_low/ 2017-04-19T22:09:40+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/biosimilar-product-authorization-chart/ 2017-04-25T19:15:51+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/biosimilar-product-authorization-chart-2/ 2017-04-25T19:18:22+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table-1/ 2017-04-25T21:18:25+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table-2/ 2017-04-25T21:19:21+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table-3/ 2017-04-25T21:19:57+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table-4/ 2017-04-25T21:20:22+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table-4-2/ 2017-04-25T21:21:43+00:00 https://mml.aeb.mwp.accessdomain.com/2017/05/12/baxalta-files-patent-infringement-suit-genentech-chugai-antibody-hemophilia-emicizumab/2017-05-04-baxalta-inc-v-genentech-complaint/ 2017-05-12T18:06:37+00:00 https://mml.aeb.mwp.accessdomain.com/2017/05/12/baxalta-files-patent-infringement-suit-genentech-chugai-antibody-hemophilia-emicizumab/us-patent-no-7033590/ 2017-05-12T18:06:57+00:00 https://mml.aeb.mwp.accessdomain.com/2017/05/26/partner-nikki-gifford-presents-world-biosimilar-congress-usa-2017/nichole-gifford-rothwell-figg_slide-deck-final/ 2017-05-26T14:42:35+00:00 https://mml.aeb.mwp.accessdomain.com/2017/05/30/janssen-files-bpcia-patent-infringement-suit-samsung-bioepiss-renflexis-infliximab-abda/janssen-biotech-v-samsung-bioepis-complaint/ 2017-05-30T16:19:18+00:00 https://mml.aeb.mwp.accessdomain.com/2017/05/30/janssen-files-bpcia-patent-infringement-suit-samsung-bioepiss-renflexis-infliximab-abda/patent-6900056/ 2017-05-30T16:20:52+00:00 https://mml.aeb.mwp.accessdomain.com/2017/05/30/janssen-files-bpcia-patent-infringement-suit-samsung-bioepiss-renflexis-infliximab-abda/patent-no-6773600/ 2017-05-30T16:20:54+00:00 https://mml.aeb.mwp.accessdomain.com/2017/05/30/janssen-files-bpcia-patent-infringement-suit-samsung-bioepiss-renflexis-infliximab-abda/patent-no-7598083/ 2017-05-30T16:20:57+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/biosimilar-product-authorization-2/ 2017-06-20T14:17:48+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table1/ 2017-06-20T14:19:34+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table2/ 2017-06-20T14:20:22+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table3/ 2017-06-20T14:21:01+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/table4/ 2017-06-20T14:21:31+00:00 https://mml.aeb.mwp.accessdomain.com/2017/06/29/sandozs-rixathon-rituximab-approved-europe/sandozs-rixathon-rituximab-approved-in-europe/ 2017-06-29T14:46:15+00:00 https://mml.aeb.mwp.accessdomain.com/2017/07/21/supreme-courts-decision-amgen-v-sandoz-clear-guidance-open-questions-biosimilars/patent-dance-steps/ 2017-07-21T17:53:39+00:00 https://mml.aeb.mwp.accessdomain.com/2017/07/21/supreme-courts-decision-amgen-v-sandoz-clear-guidance-open-questions-biosimilars/amgen-v-sandoz-2017-scotus-bcpia-notice-of-commercial-marketing/ 2017-07-21T18:05:15+00:00 https://mml.aeb.mwp.accessdomain.com/2017/08/09/samsung-bioepis-merck-launch-renflexis-u-s/biosimilars-approved-by-fda-biosimilarsip/ 2017-08-09T16:11:47+00:00 https://mml.aeb.mwp.accessdomain.com/2017/08/15/abbvie-files-bpcia-suit-boehringer-ingelheim-humira-adalimumab/abbvie-complaint/ 2017-08-15T22:03:30+00:00 https://mml.aeb.mwp.accessdomain.com/2017/08/17/impact-biosimilars-global-pharmaceutical-markets/the-impact-of-biosimilars-on-global-pharmaceutical-markets/ 2017-08-17T13:04:27+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/biosimilar-product-authorization_september-2017/ 2017-09-07T13:51:32+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/european-medicines-agency-list-of-approved-biosimilars_september-2017/ 2017-09-07T13:55:17+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/european-medicines-agency-list-of-approved-biosimilars_september-2017-2/ 2017-09-07T14:10:14+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/us-fda-list-of-approved-biosimilars_september-2017/ 2017-09-07T14:13:47+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-biosimilars-uder-evaluation_september-2017/ 2017-09-07T14:15:22+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/biologics-with-recent-or-nearing-patent-expiry_september-2017/ 2017-09-07T14:16:57+00:00 https://mml.aeb.mwp.accessdomain.com/2017/09/07/u-s-compares-europe-biosimilar-approvals-products-pipeline/biosimilar-product-authorization_september-2017-2/ 2017-09-07T14:18:43+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/04/pfizer-files-another-ipr-genentechs-%ca%bc441-patent/petition-2018-00016/ 2017-10-04T19:39:42+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/12/pfizer-seeks-inter-partes-review-rituximab-patents/pfizer-161-decision-to-join-and-institute/ 2017-10-12T20:59:41+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/12/pfizer-seeks-inter-partes-review-rituximab-patents/2017-02127-petition-pfizer-711-patent/ 2017-10-12T21:00:38+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/12/pfizer-seeks-inter-partes-review-rituximab-patents/2017-02126-petition-pfizer-612-patent/ 2017-10-12T21:00:45+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/17/genentechs-carter-%ca%bc213-patent-continues-draw-ipr-challenges/genentech-carter-213/ 2017-10-17T14:28:34+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/23/ptab-denies-institution-rituxan-iprs-petitioner-failed-establish-certain-references-publicly-available/celltrion-2017-1227-denial/ 2017-10-23T20:12:36+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/23/ptab-denies-institution-rituxan-iprs-petitioner-failed-establish-certain-references-publicly-available/celltrion-2017-1229-denial/ 2017-10-23T20:12:39+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/23/ptab-denies-institution-rituxan-iprs-petitioner-failed-establish-certain-references-publicly-available/celltrion-2017-1230_denial/ 2017-10-23T20:12:41+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/26/ptab-institutes-review-four-celltrion-petitions-targeting-herceptin/2017-1121-institution-decision/ 2017-10-26T13:35:57+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/26/ptab-institutes-review-four-celltrion-petitions-targeting-herceptin/2017-1122-institution-decision/ 2017-10-26T13:36:01+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/26/ptab-institutes-review-four-celltrion-petitions-targeting-herceptin/2017-1139-institution-decision/ 2017-10-26T13:36:03+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/26/ptab-institutes-review-four-celltrion-petitions-targeting-herceptin/2017-1140-institution-decision/ 2017-10-26T13:36:06+00:00 https://mml.aeb.mwp.accessdomain.com/2017/10/26/ptab-institutes-review-four-celltrion-petitions-targeting-herceptin/2017-1121-institution-decision-2/ 2017-10-26T13:36:44+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/13/humiras-wall-patents-continues-come-attack/table-1-iprs-filed-by-sandoz-inc-against-humira-patents/ 2017-11-13T18:34:03+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/biosimilar-product-authorization-as-of-november-16-2017/ 2017-11-16T14:51:28+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-list-of-approved-biosimilar-drugs-as-of-november-16-2017-2/ 2017-11-16T14:56:06+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-list-of-approved-biosimilar-drugs-as-of-november-16-2017-3/ 2017-11-16T14:56:35+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-list-of-approved-biosimilar-drugs-as-of-november-16-2017/ 2017-11-16T14:56:52+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-list-of-approved-biosimilar-drugs-as-of-november-16-2017-4/ 2017-11-16T14:57:11+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-list-of-approved-biosimilar-drugs-as-of-november-16-2017-5/ 2017-11-16T15:03:12+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-approved-biosimilar-drugs-11-16-2017/ 2017-11-16T15:09:59+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-approved-biosimilar-drugs-11-16-2017-2/ 2017-11-16T15:10:25+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/fda-approved-biosimilar-drugs-as-of-11-16-2017/ 2017-11-16T15:15:54+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-biosimilars-under-evaluation-11-16-2017/ 2017-11-16T15:17:12+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/us-biologics-near-primary-patent-expiry/ 2017-11-16T15:18:22+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-approved-biosimilars-11-16-17/ 2017-11-21T19:03:48+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-approved-biosimilars-11-16-17-2/ 2017-11-21T19:04:02+00:00 https://mml.aeb.mwp.accessdomain.com/2017/11/16/update-u-s-compares-europe-biosimilar-approvals-products-pipeline/ema-approved-biosimilars-11-16-17-3/ 2017-11-21T19:04:14+00:00 https://mml.aeb.mwp.accessdomain.com/2017/12/27/amgen-files-petition-rehearing-en-banc-praluent-written-description-enablement-issues/17-1480-amgen-petition-for-rehearing-en-banc/ 2017-12-27T16:33:44+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/15/celltrion-teva-file-declaratory-judgment-action-thirty-eight-herceptin-related-patents/2018-01-15-celltrion-teva-patents-in-suit/ 2018-01-15T16:29:40+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/15/celltrion-teva-file-declaratory-judgment-action-thirty-eight-herceptin-related-patents/celltrion-dj-v-genetech/ 2018-01-15T16:30:45+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/16/celltrion-teva-file-declaratory-judgment-action-thirty-seven-rituxan-related-patents/celltrion-teva-patents-in-suit/ 2018-01-16T18:57:02+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/16/celltrion-teva-file-declaratory-judgment-action-thirty-seven-rituxan-related-patents/518-cv-00276/ 2018-01-16T19:02:52+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/22/amicus-brief-filed-biopharmaceutical-companies-support-amgens-petition-rehearing-en-banc/amgen-v-sanofi-amicus-brief-of-bristol-myers-squibb-bavarian-nordic-and-enzo-biochem/ 2018-01-22T19:25:38+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/biosimilars-product-authorizations-december-13-2017/ 2018-01-24T15:15:04+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/european-medicines-agency-lis-of-approved-biosimilars-drugs-january-16-2018/ 2018-01-24T15:18:17+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/european-medicines-agency-lis-of-approved-biosimilars-drugs-january-16-2018-2/ 2018-01-24T15:18:34+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/european-medicines-agency-lis-of-approved-biosimilars-drugs-january-16-2018-3/ 2018-01-24T15:19:02+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/ema-approved-biosimilars-drugs-january-16-2018/ 2018-01-24T15:19:47+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/ema-approved-biosimilars-drugs-january-16-2018-2/ 2018-01-24T15:20:00+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/us-fda-approved-biosimilar-drugs-december-13-2017/ 2018-01-24T15:23:04+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/ema-biosimilars-under-evaluation-january-4-2018/ 2018-01-24T15:24:34+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/biologics-nearing-patent-expiry-in-us/ 2018-01-24T15:25:53+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/biosimilars-product-authorizations/ 2018-01-24T19:31:29+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/ema-approved-biosimilars-drugs-january-24-2018/ 2018-01-24T19:37:58+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/us-fda-approved-biosimilar-drugs-december-13-2017-2/ 2018-01-24T19:41:06+00:00 https://mml.aeb.mwp.accessdomain.com/2018/01/24/update-u-s-compares-europe-biosimilar-approvals-products-pipeline-2/ema-biosimilars-under-evaluation-january-4-2018-2/ 2018-01-24T19:42:45+00:00 https://mml.aeb.mwp.accessdomain.com/2018/03/05/genentechs-carter-213-patent-asserted-challenged/pfizer-v-genentech/ 2018-03-05T15:10:34+00:00 https://mml.aeb.mwp.accessdomain.com/2018/04/18/ptab-institutes-review-of-an-abbvie-patent-directed-to-treatment-of-psoriatic-arthritis-comprising-administration-of-adalimumab/ipr2017-02106-institution/ 2018-04-18T17:06:07+00:00 https://mml.aeb.mwp.accessdomain.com/2018/04/19/ptab-institutes-review-of-abbvie-patent-directed-to-treatment-of-chronic-plaque-psoriasis/2017-02105-institution-humira-cpp/ 2018-04-19T17:33:30+00:00 https://mml.aeb.mwp.accessdomain.com/2018/04/20/fujifilm-and-mylan-announce-partnership-to-commercialize-adalimumab-biosimilar/fujifilm-mylan-humira-announcement/ 2018-04-20T15:46:00+00:00 https://mml.aeb.mwp.accessdomain.com/2018/04/26/final-judgment-entered-in-amgen-v-coherus-neulasta-litigation/judge-stark-order/ 2018-04-26T14:19:47+00:00 https://mml.aeb.mwp.accessdomain.com/2018/04/26/final-judgment-entered-in-amgen-v-coherus-neulasta-litigation/judge-burke-report/ 2018-04-26T14:19:58+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/02/how-the-u-s-compares-to-europe-on-biosimilar-approvals-and-products-in-the-pipeline/biosimilar-product-authorizations_5_2018/ 2018-05-02T15:40:59+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/02/how-the-u-s-compares-to-europe-on-biosimilar-approvals-and-products-in-the-pipeline/ema-approved-biosimilars_5_2018/ 2018-05-02T15:41:38+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/02/how-the-u-s-compares-to-europe-on-biosimilar-approvals-and-products-in-the-pipeline/ema-approved-biosimilars_5_2018-2/ 2018-05-02T15:41:53+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/02/how-the-u-s-compares-to-europe-on-biosimilar-approvals-and-products-in-the-pipeline/fda-approved-biosimilars_5_2018/ 2018-05-02T15:42:36+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/02/how-the-u-s-compares-to-europe-on-biosimilar-approvals-and-products-in-the-pipeline/ema-biosimilars-under-evaluation_5_2018/ 2018-05-02T15:43:17+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/02/how-the-u-s-compares-to-europe-on-biosimilar-approvals-and-products-in-the-pipeline/us-biomsilars-expiration_5_2018/ 2018-05-02T15:43:46+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/07/sandoz-receives-complete-response-letter-from-fda-for-proposed-rituximab-biosimilar/2018-05-02-sandoz-crl-rituximab/ 2018-05-07T17:42:33+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/07/sandoz-receives-complete-response-letter-from-fda-for-proposed-rituximab-biosimilar/2017-09-12-sandoz-bla-rituximab/ 2018-05-07T17:42:39+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/10/ptab-denies-inter-partes-review-of-rituxan-patents/ipr2017-02127/ 2018-05-10T15:37:56+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/10/ptab-denies-inter-partes-review-of-rituxan-patents/ipr2017-02126/ 2018-05-10T15:37:59+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/10/ptab-denies-inter-partes-review-of-rituxan-patents/ipr2017-02127-2/ 2018-05-10T15:38:20+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/11/district-court-grants-genentechs-motions-to-dismiss-celltrions-declaratory-judgment-actions-in-herceptin-and-rituxan-related-suits/genentech-motion-to-dismiss/ 2018-05-11T18:26:34+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/18/celltrion-seeks-joinder-with-pfizer-ipr-challenging-rituximab-related-patent/celltrion-motion-requesting-dismissal/ 2018-05-18T14:08:32+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/18/celltrion-seeks-joinder-with-pfizer-ipr-challenging-rituximab-related-patent/celltrion-motion-for-joinder/ 2018-05-18T14:08:35+00:00 https://mml.aeb.mwp.accessdomain.com/2018/05/29/litigation-spotlight-the-adello-filgrastim-neupogen-litigation/wooden-brown-judges-gavel-isolated-on-black-2/ 2018-06-24T00:30:35+00:00